Yadav, Ambedkar Kumar’s team published research in Annals of palliative medicine in 2021-01-11 | CAS: 55981-09-4

Annals of palliative medicine published new progress about Coronavirus disease 2019 (COVID-19); antiviral; coronavirus; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); therapeutic agents; treatment. 55981-09-4 belongs to class esters-buliding-blocks, name is 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate, and the molecular formula is C12H9N3O5S, Name: 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate.

Yadav, Ambedkar Kumar published the artcileAntiviral treatment in COVID-19: which is the most promising?-a narrative review., Name: 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate, the main research area is Coronavirus disease 2019 (COVID-19); antiviral; coronavirus; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); therapeutic agents; treatment.

The whole world is battling through coronavirus disease 2019 (COVID-19) which is a fatal pandemic. In the early 2020, the World Health Organization (WHO) declared it as a global health emergency without definitive treatments and preventive approaches. In the absence of definitive therapeutic agents, this thorough review summarizes and outlines the potency and safety of all molecules and therapeutics which may have potential antiviral effects. A number of molecules and therapeutics licensed or being tested for some other conditions were found effective in different in vitro studies as well as in many small sample-sized clinical trials and independent case studies. However, in those clinical trials, there were some limitations which need to be overcome to find the most promising antiviral against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In conclusion, many of above-mentioned antivirals seems to have some therapeutic effects but none of them have been shown to have a strong evidence for their proper recommendation and approval in the treatment of COVID-19. Constantly evolving new evidences, exclusive adult data, language barrier, and type of study (observational, retrospective, small-sized clinical trials, or independent case series) resulted to the several limitations of this review. The need for multicentered, large sample-sized, randomized, placebo-controlled trials on COVID-19 patients to reach a proper conclusion on the most promising antiviral agent is warranted.

Annals of palliative medicine published new progress about Coronavirus disease 2019 (COVID-19); antiviral; coronavirus; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); therapeutic agents; treatment. 55981-09-4 belongs to class esters-buliding-blocks, name is 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate, and the molecular formula is C12H9N3O5S, Name: 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics